Replies to post #7160 on Momenta Pharmaceuticals, Inc. (MNTA)

[investorgold2002]

iwfal -

"c) Momenta sues them for patent infringement on a generic that is not hurting them in any way "


I see potential of licensing fee revenue accruing to MNTA from biogeneric players(the biogeneric that MNTA has no intent to produce for whatever reason)

To me(layman) that cell host line patent looks overarching and may apply to host of biologics as indicated in that patent itself